| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
1e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
4e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
5e-05 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |